New Chemotherapy Robot to Benefit Patients at the UM Greenebaum Cancer Center

July 7, 2013

System purchased with $1.2 million gift from Roslyn and Len Stoler

The University of Maryland Marlene and Stewart Greenebaum Cancer Center unveiled a new $1.2 million chemotherapy robot on Thursday, July 11, 2013, at a ceremony at the University of Maryland Medical Center . The robot was purchased with a gift from Roslyn and Leonard Stoler and named for their granddaughter who was successfully treated for cancer nearly 20 years.

The robot, which is manufactured by an Italian company, will streamline how cancer-fighting drugs are compounded for patients, not only reducing the waiting time but also providing added precision and safety to the preparation process. It is capable of preparing up to 12 doses of chemotherapy an hour, three times what a pharmacist or technician can do in the same amount of time. The cancer center's Katz pharmacy currently prepares 80 to 90 doses of chemotherapy daily for patients.

The Apoteca chemotherapy robot has built-in quality control mechanisms, such as bar-coding and weighing, that provide increased accuracy. It precisely performs calculations that are required for dosing and double checks the measurements while recording them automatically and consistently.

The Stolers are longtime benefactors of the Greenebaum Cancer Center. In 2005, they donated $5 million toward a new outpatient center, the Roslyn and Leonard Stoler Pavilion. Mr. Stoler is founder and president of Len Stoler Automotive, which owns 13 auto dealerships in the Baltimore area. Mrs. Stoler is a member of the cancer center's advisory board.

Your gift of financial support can make a difference in patients' lives. For more information on supporting the University of Maryland Greenebaum Cancer Center, call the UMMS Foundation at 410-328-5770.


All active news articles